Arysta LifeScience CEO Net Worth

Last Updated Mar 10, 2025
CEO NameAnand Nambiar
NationalityIndia
Net Worth Estimation$5 million

Anand Nambiar, current CEO of Arysta LifeScience, has an estimated net worth of around $5 million, primarily derived from his executive compensation, long-term incentives, and equity holdings in the agrochemical and life sciences sector. His strategic leadership within leading industry companies and involvement in high-value mergers and acquisitions have further contributed to his financial standing.

Anand Nambiar, CEO of Arysta LifeScience in the agriculture sector, has an estimated net worth of $5,000,000. This places him at approximately 6.1% of the maximum and 400% of the minimum estimated CEO net worth in this field.

Business Category: Agriculture

Minimum Net Worth (estimation): 1000000 USD
Maximum Net Worth (estimation): 70000000 USD


Anand Nambiar Performance in Arysta LifeScience

Anand Nambiar, CEO of Arysta LifeScience, demonstrated strategic leadership by driving innovation and operational efficiency within the agrochemical sector. His decision-making emphasized market expansion and integration of sustainable practices, resulting in enhanced competitive positioning. Under his leadership, Arysta LifeScience achieved significant growth and improved performance metrics, solidifying its industry presence.


Latest News

Arysta LifeScience Acquisition and CEO Leadership Updates

Arysta LifeScience was acquired by UPL Limited for $4.2 billion in 2018, marking a transformative expansion in UPL's agricultural solutions portfolio under CEO Jai Shroff, who emphasized the company's commitment to sustainable growth and innovation. Previously, Arysta was acquired by Platform Specialty Products in 2014 for $3.5 billion, with Wayne Hewett serving as Arysta's CEO before the sale to UPL.
Source: http://chemanager-online.com/en/news/platform-completes-acquisition-of-arysta



Disclaimer.
The information provided in this document is for general informational purposes only and is not guaranteed to be complete. While we strive to ensure the accuracy of the content, we cannot guarantee that the details mentioned are up-to-date or applicable to all scenarios. Topics about Arysta LifeScience are subject to change from time to time.

Comments

No comment yet